References in periodicals archive ?
Pharmaceuticals company Sagent Pharmaceuticals (NasdaqGS:SGNT) reported on Monday the availability of an anti-infective/antibiotic Amikacin Sulfate Injection, USP in 500 mg per 2 ml and 1 g per 4 ml preservative-free vials in the market.
Contract awarded for acquisition omeprazol, phenytoin sodium, dobutamine, oxitocina, amikacin sulfate, departmental hospital for solol
5 mL, Fallon Wellness Pharmacy, Latham, NY, USA) and amikacin sulfate (20 mg/kg), and a patch was placed over the defect with a nonadherent wound dressing and tape.
Amikacin sulfate pharmaceutical form: injection solution; concentration: 50mg / 1ml; route of administration: im;,calcium gluconate pharmaceutical form: injection solution; concentration: 10%; route of administration: intravenous; ampoule 10 ml,potassium chloride concentration: 10% (20meq / 10ml); presentation: blister; route of administration: iv; ampoule 10 ml,hypertonic dextrose pharmaceutical form: liquid injection; concentration: 10%; route of administration: intravenous; bag 250 ml,dextrose and sodium chloride pharmaceutical form: injectable solution; concentration: 3.